| Financial Year |
March 31 2023 |
| Monetary Funds |
431,849,158.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
191,239,705.59 |
| Accounts Receivable |
1,526,051,618.78 |
| Advances to Suppliers |
44,430,625.69 |
| Other Receivables |
47,740,941.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
910,540,609.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,614,954.53 |
| Total Current Assets |
3,162,467,614.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
622,579,954.25 |
| Under-construction Projects |
135,708,354.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
82,336,461.97 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,640,611.00 |
| Deferred Income Tax Assets |
49,018,020.18 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
913,896,417.54 |
| Total Assets |
4,076,364,032.00 |
| Short-Term Loans |
275,011,305.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
443,876,101.97 |
| Accounts Payable |
1,057,452,029.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
87,493,093.38 |
| Taxes Payable |
9,215,914.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
43,051,318.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,447,545.96 |
| Other Current Liabilities |
3,213,796.02 |
| Sub-Total of Current Liabilities |
1,982,367,480.00 |
| Long-term Loans |
46,423,883.06 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
36,808,060.54 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
182,451,374.13 |
| Total Liabilities |
2,164,818,854.13 |
| Paid-In Capital(Or Share Stock) |
604,692,321.00 |
| Capital Surplus |
176,958,536.33 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
2,596,668.23 |
| Undistributed Profits |
994,137,952.81 |
| Minority Stockholder's Interest |
127,063,704.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,784,481,472.91 |
| Owner's Equity（Stockholder's Equity） |
1,911,545,177.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,076,364,032.00 |
